# Evaluation of Effect of Vonoprazan on Midazolam Pharmacokinetics in Healthy Participants

> **NCT04545944** · PHASE1 · COMPLETED · sponsor: **Phathom Pharmaceuticals, Inc.** · enrollment: 20 (actual)

## Conditions studied

- Healthy Volunteers

## Interventions

- **DRUG:** Vonoprazan
- **DRUG:** Midazolam

## Key facts

- **NCT ID:** NCT04545944
- **Lead sponsor:** Phathom Pharmaceuticals, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-09-15
- **Primary completion:** 2020-11-13
- **Final completion:** 2020-11-25
- **Target enrollment:** 20 (ACTUAL)
- **Last updated:** 2023-03-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04545944

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04545944, "Evaluation of Effect of Vonoprazan on Midazolam Pharmacokinetics in Healthy Participants". Retrieved via AI Analytics 2026-06-11 from https://api.ai-analytics.org/clinical/NCT04545944. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*